Aldeyra Therapeutics Inc.

NASDAQ: ALDX · Real-Time Price · USD
2.48
0.13 (5.53%)
At close: Jun 04, 2025, 3:59 PM
2.41
-2.63%
After-hours: Jun 04, 2025, 06:58 PM EDT

Aldeyra Therapeutics Statistics

Share Statistics

Aldeyra Therapeutics has 59.9M shares outstanding. The number of shares has increased by 0.5% in one year.

Shares Outstanding 59.9M
Shares Change (YoY) 0.5%
Shares Change (QoQ) 0.27%
Owned by Institutions (%) 62.48%
Shares Floating n/a
Failed to Deliver (FTD) Shares 69,720
FTD / Avg. Volume 3.88%

Short Selling Information

The latest short interest is 4.75M, so 7.94% of the outstanding shares have been sold short.

Short Interest 4.75M
Short % of Shares Out 7.94%
Short % of Float 8.18%
Short Ratio (days to cover) 3.04

Valuation Ratios

The PE ratio is -5.31 and the forward PE ratio is 19.14. Aldeyra Therapeutics's PEG ratio is -0.11.

PE Ratio -5.31
Forward PE 19.14
PS Ratio 0
Forward PS 0.7
PB Ratio 4.18
P/FCF Ratio -6.87
PEG Ratio -0.11
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Aldeyra Therapeutics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.48, with a Debt / Equity ratio of 0.22.

Current Ratio 5.48
Quick Ratio 5.48
Debt / Equity 0.22
Debt / EBITDA -0.25
Debt / FCF -0.35
Interest Coverage -31.21

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee n/a
Profits Per Employee $-6,205,716
Employee Count 9
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -42.54% in the last 52 weeks. The beta is 0.68, so Aldeyra Therapeutics's price volatility has been higher than the market average.

Beta 0.68
52-Week Price Change -42.54%
50-Day Moving Average 2.86
200-Day Moving Average 4.85
Relative Strength Index (RSI) 47.09
Average Volume (20 Days) 1,796,768

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -60.12M
Net Income -55.85M
EBITDA -60.12M
EBIT -57.78M
Earnings Per Share (EPS) -0.94
Full Income Statement

Balance Sheet

The company has 54.53M in cash and 15.3M in debt, giving a net cash position of 39.22M.

Cash & Cash Equivalents 54.53M
Total Debt 15.3M
Net Cash 39.22M
Retained Earnings -450.11M
Total Assets 93.2M
Working Capital 77M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -43.21M and capital expenditures 0, giving a free cash flow of -43.21M.

Operating Cash Flow -43.21M
Capital Expenditures n/a
Free Cash Flow -43.21M
FCF Per Share -0.73
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ALDX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for ALDX is $9.5, which is 304.3% higher than the current price. The consensus rating is "Buy".

Price Target $9.5
Price Target Difference 304.3%
Analyst Consensus Buy
Analyst Count 2
Stock Forecasts

Scores

Altman Z-Score -5.2
Piotroski F-Score 2